UCLA Health

The findings mark the first time this regimen has demonstrated a survival benefit in the vast majority of patients with metastatic colorectal cancer.

Researchers say cell-free DNA can also distinguish between different neurological diseases.

Multiple subspecialties ranked in the U.S. News & World Report assessment.

Inhalers have generated over 2 million metric tons of carbon emissions annually over the past decade.

Dr. Beate Ritz’s research in California’s Central Valley highlights the role of the environment in the neurodegenerative disorder.

10 pediatric oncology patients at UCLA Health who were guests of Major League Baseball’s Childhood Cancer Awareness Night.

Recent headlines show how UCLA research findings and ongoing studies are making an impact across the nation and the globe.

An email to renowned autism investigator Dr. Daniel Geschwind is leading to new science.

The study found pembrolizumab shrank or eliminated tumors in nearly 90% of participants with desmoplastic melanoma that cannot be surgically removed.

Hyundai Hope on Wheels has awarded nearly $2.8 million to support Dr. Steven Jonas’ research at UCLA.

The clinical trial demonstrates that combining genetically engineered T cells and stem cells can produce cancer-fighting immune cells in humans.

Researchers outline how screening, equity and policy can save more lives from colorectal cancer.

The comprehensive 17-year study finds rising mortality, chronic illness and mental health challenges among U.S. children and youth.

The groundbreaking work is a scientific first.

Researchers found that very small elevations in two biomarkers are strong and independent predictors of overall cancer risk.

The algorithm unlocks the full potential of proteogenomics by overcoming a key challenge in linking genetic mutations to protein-level changes.

Before the Netflix hit, UCLA’s Elizabeth Laugeson was running her own dating course for autistic adults.

UCLA Health and UCLA Library partner to support student well-being at one of the busiest times of the year.

A widely prescribed drug boosted the ability of T cells to fight cancer and suppressed growth in mouse and human tumor models.

UCLA researchers looked at how using MRI, MRI-guided biopsies and focal therapy can help men with prostate cancer remain on active surveillance.

Using artificial intelligence during routine screening could flag spots of concern invisible to the naked eye.

The gift was inspired by the family’s personal experiences with UCLA.

Herbert Najera discusses his journey to a career in health care.

The donation allows UCLA Health to add a second mobile stroke unit, which will serve the San Fernando Valley.

A team led by UCLA Health Jonsson Comprehensive Cancer Center doctors Dennis Slamon and Richard Finn, helped transform breast cancer treatment.